(48 days)
Not Found
No
The summary describes a mechanical catheter for drug delivery and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.
Yes
The device is described as delivering "therapeutic and diagnostic agents" and "therapeutics to the bronchial tissue," which directly implies a therapeutic purpose.
Yes
The "Intended Use / Indications for Use" states that the device is intended to "deliver therapeutic and diagnostic agents".
No
The device description clearly outlines a physical catheter with various hardware components (infusion port, balloon, catheter shaft, valve, hub). The performance studies also focus on mechanical and material properties, further indicating it is a hardware device.
Based on the provided information, the Blowfish™ Transbronchial Micro-Infusion Catheter is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "deliver therapeutic and diagnostic agents" into the airway tree. This describes a device used for delivering substances to the body, not for examining specimens taken from the body to diagnose a condition.
- Device Description: The description details a catheter designed to be inserted into the airway and inflated to deliver agents into the tissue. This is a delivery device, not a diagnostic test performed on a sample outside the body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. The device's function is purely about delivering substances.
Therefore, the Blowfish™ Transbronchial Micro-Infusion Catheter is a therapeutic/delivery device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Blowfish™ Transbronchial Micro-Infusion Catheter is intended to deliver therapeutic and diagnostic agents that are indicated or labeled for airway, tracheal or bronchial delivery into selected and sub-selected regions of the airway tree.
Product codes (comma separated list FDA assigned to the subject device)
EOQ
Device Description
The Blowfish™ Transbronchial Micro-Infusion Catheter is a bronchoscope guided, single-operator, catheter that consists of a microscopic, tapered stainless steel infusion port, a semi-rigid/semi-elastic polymer balloon, a composite metal and polymer catheter shaft, a pressure relief valve and a proximal hub with standard luer attachment fittings. The device is designed to be advanced through a bronchoscope to a target location in the tracheobronchial three and inflated to move the micro-infusion port into the airway wall to deliver therapeutics to the bronchial tissue including the bronchial adventitia.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
airway, tracheal or bronchial
Tracheobronchial Tree
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Device performance of the Blowfish Transbronchial Micro-Infusion Catheter was tested in bench, in vitro and in vivo animal studies. Performance testing was conducted to verify that it meets the mechanical performance requirements defined by the product specification after exposure to E-Beam irradiation, aging and simulated distribution. All tests met the pre-determined acceptance criteria.
The testing included the following:
- mechanical and fluid delivery performance .
- . packaging and labeling testing
- shelf-life testing .
- biocompatibility per ISO 10993-1: cytotoxicity, sensitization, intracutanious . reactivity and acute toxicity, was previously conducted with a legally marketed device (K062752)
- in-vivo safety studies using a porcine model .
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.4680 Bronchoscope (flexible or rigid) and accessories.
(a)
Identification. A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.(b)
Classification. Class II.
0
KI 31401
510(k) Notification Blowfish Transbronchial Micro-Infusion Catheter
JUL 0 2 2013
5. 510(K) SUMMARY
510(k) Applicant Mercator MedSystems, Inc. 1670 Alvarado Suite # 4 San Leandro, CA 94577 Telephone: (510) 614-4550 Facsimile: (510) 614-4560
| Contact Person: | Plamena Entcheva-Dimitrov, PhD, RAC |
|---|---|
| Phone: | (510) 614-4550 |
| Facsimile: | (510) 614-4560 |
| Email: | ped@mercatormed.com |
| Date of Summary: | 27 June 2013 |
| Device Overview | |
| Trade Name: | Blowfish™ Transbronchial Micro-Infusion Catheter |
| Common Name: | Transbronchial Catheter |
| Classification: | Bronchoscope (flexible or rigid) and Accessories |
| 21 CFR 874.4680 | |
| Product Code EOQ | |
| Panel: | ENT |
Predicate Devices
| 510(k) Number | Product Name | Manufacturer |
|---|---|---|
| K962901 | Olympus B5-2C/B7-2C | |
| Balloon Catheter | Olympus |
Device Description
The Blowfish™ Transbronchial Micro-Infusion Catheter is a bronchoscope guided, single-operator, catheter that consists of a microscopic, tapered stainless steel infusion port, a semi-rigid/semi-elastic polymer balloon, a composite metal and polymer catheter shaft, a pressure relief valve and a proximal hub with standard luer attachment fittings. The device is designed to be advanced through a bronchoscope to a target location in the tracheobronchial three and inflated to move the micro-infusion port into the airway wall to deliver therapeutics to the bronchial tissue including the bronchial adventitia.
Intended Use
Bronchoscope accessories in the airway tree for medicine infusion.
1
510(k) Notification
Blowfish Transbronchial Micro-Infusion Catheter
Indications for Use
The Blowfish™ Transbronchial Micro-Infusion Catheter is intended to deliver therapeutic and diagnostic agents that are indicated or labeled for airway, tracheal or bronchial delivery into selected and sub-selected regions of the airway tree.
Comparison to Predicate Device
The Blowfish Transbronchial Micro-Infusion Catheter is substantially equivalent to the predicate. The Blowfish Transbronchial Micro-Infusion Catheter has the same intended use, methods of introduction and methods of operation. Risk analysis has shown that the Blowfish Transbronchial Micro-Infusion Catheter has the same risk profile as the predicate. The Indication for Use statement of the predicate is broader and includes selective endoscopic bronchography, medicine injection to bronchi, saline injection associated with bronchoalveolar lavage, foreign body removal from bronchi and bronchial hemostasis, while the Indication for Use statement for the Blowfish Transbronchial Micro-Infusion Catheter is only limited to the medicine injection portion of the predicate. By selecting a narrower Indication for Use statement compared to the predicate. Mercator believes that the differences in the wording are not critical and thus the requirement of 807.92(a)(5) is met.
| NAME /
510(K) NUMBER | Blowfish Transbronchial Micro-
Infusion Catheter (Current
Submission) | Olympus B5-2C/B7-2C Balloon
Catheter / K962901 |
|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| MANUFACTURER | Mercator MedSystems | Olympus |
| INTENDED USE | Bronchoscope accessories in the
airway tree for medicine infusion. | Bronchoscope accessories in the
airway tree for medicine infusion. |
| INDICATIONS FOR USE | The BlowfishTM Transbronchial
Micro-Infusion Catheter is intended
to deliver therapeutic and
diagnostic agents that are indicated
or labeled for airway, tracheal or
bronchial delivery into selected and
sub-selected regions of the airway
tree. | Olympus B5-2C/B7-2C Balloon
Catheters are to be used for
selective endoscopic
bronchography, medicine
injection to bronchi, saline
injection associated with
bronchoalveolar lavage, foreign
body removal from bronchi and
bronchial hemostasis. |
| TARGETED LOCATION
INFUSION | Tracheobronchial Tree | Tracheobronchial Tree |
| Delivery Method into the
Bronchi | Infusion via a Stainless Steel Port | Infusion via Polymer Port |
| Number of Delivery Ports | One (on the side) | One (at the tip) |
| Delivery Port Size | 34 Gauge | Unknown |
| ACTUATOR / BALLOON | | |
| Material | Parylene and Silicone | Natural Rubber Latex |
| Target Diameter | 6.0 mm to 16.0 mm | 11 mm |
| Max Inflation Pressure | 2 atm controlled by pressure relief
valve | No pressure relief valve |
| Shape (cross-section) | U-shaped balloon sheathing micro-
infusion port | O-shaped balloon surrounding
infusion port |
| Inflation medium | Liquid | Air (max 2.1 mL) |
| CATHETER | | |
| Material | Polymer | Unknown |
Comparison of Kev Technological Characteristics
Section 5 Mercator MedSystems, Inc. Page 5-2
2
510(k) Notification Blowfish Transbronchial Micro-Infusion Catheter
| NAME /
510(K) NUMBER | Blowfish Transbronchial Micro-
Infusion Catheter (Current
Submission) | Olympus B5-2C/B7-2C Balloon
Catheter / K962901 |
|----------------------------|-----------------------------------------------------------------------------|---------------------------------------------------------------------------------|
| Length | Up to 145 cm | 105 cm |
| BRONCHOSCOPE
CHANNEL ID | 2.8 mm | 2.0 - 2.8 mm |
| PACKAGING | Tyvek Pouch | Tyvek Pouch |
| STERILIZATION METHOD | E-beam | Ethylene Oxide |
| STERILITY | Sterile (SAL 10-6) | Sterile (SAL 10-6) |
| SINGLE USE | Yes | Yes |
| STORAGE | Room Temperature | Ambient temperature 10°C –
40°C (50°F – 104°F)
Relative Humidity 30 – 85% |
Performance Data
Device performance of the Blowfish Transbronchial Micro-Infusion Catheter was tested in bench, in vitro and in vivo animal studies. Performance testing was conducted to verify that it meets the mechanical performance requirements defined by the product specification after exposure to E-Beam irradiation, aging and simulated distribution. All tests met the pre-determined acceptance criteria.
The testing included the following:
- mechanical and fluid delivery performance .
- . packaging and labeling testing
- shelf-life testing .
- biocompatibility per ISO 10993-1: cytotoxicity, sensitization, intracutanious . reactivity and acute toxicity, was previously conducted with a legally marketed device (K062752)
- in-vivo safety studies using a porcine model .
Conclusion
When compared to the predicate device, the Blowfish Transbronchial Micro-Infusion Catheter has the same intended use and target location. Test results indicated that the catheter's materials, mode of action and procedure (i.e. via a bronchoscope) are safe and do not raise different questions of safety and effectiveness compared to the predicate device (Olympus B5-2C/B7-2C Balloon Catheter, K962901). The materials included in the Blowfish Transbronchial Micro-Infusion Catheter were tested and demonstrated to be biocompatible and safe. The Blowfish Transbronchial Micro-Infusion Catheter labeling contains instructions for use and any necessary cautions and warnings to assure safe and effective use of the device.
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a traditional symbol of medicine, but with three bars instead of one.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue
Document Control Center - WO66-G609 Silver Spring, MD 20993-4002
July 2, 2013
Mercator MedSystems, Inc. c/o Mr. Mark Job Regulatory Technology Services. LLC 1394 25th Street, NW Buffalo. MN 55313
Re: K131401
Trade/Device Name: Blowfish™ Transbronchial Micro-Infusion Catheter Regulation Number: 21 CFR 874.4680 Regulation Name: Transbronchial Catheter Regulatory Class: Class II Product Code: EOQ Dated: May 14, 2013 Received: May 15, 2013
Dear Mark Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Mark Job
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fdagov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Eric A. Mann -S
for Malvina B. Eydelman, M.D. Director
Division of Ophthalmic and Ear. Nose and Throat Devices Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
5
5 10(k) Notification
Blowfish Transbronchial Micro-Infusion Catheter
4. INDICATIONS FOR USE STATEMENT
510(k) Number: K131401
Device Name: BlowfishTM Transbronchial Micro-Infusion Catheter
Indications For Use:
The Blowfish™ Transbronchial Micro-Infusion Catheter is intended to deliver therapeutic and diagnostic agents that are indicated or labeled for airway, tracheal or bronchial delivery into selected and sub-selected regions of the airway tree.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Eric A. Mann -S
Section 4 Mercator MedSystems, Inc.